We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

96 hedge funds and large institutions have $455M invested in AMAG Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 96 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more call options, than puts

Call options by funds: $926K | Put options by funds: $296K

94.33% more ownership

Funds ownership: 0% → 94.33% (+94%)

Holders
96
Holders Change
+96
Holders Change %
–
% of All Funds
3.12%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
96
Increased
–
Reduced
–
Closed
–
Calls
$926K
Puts
$296K
Net Calls
+$630K
Net Calls Change
+$630K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

AMAG Hedge Fund Activity: Q2 2013 in Review

96 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q2 2013, worth a combined $455M.

Buyers outnumbered sellers: 96 funds opened new AMAG positions and 0 closed out — a net gain of 96 holders — while 0 added to existing stakes and 0 trimmed.

  • 96 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $455M of AMAG Pharmaceuticals stock for Q2 2013.
  • 96 funds opened new AMAG Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +96 holders.

Based on aggregated 13F filings for Q2 2013.